RNAi nanomaterials targeting immune cells as an anti-tumor therapy: the missing link in cancer treatment?
siRNA delivery targeting tumor cells and cancer-associated immune cells has been gaining momentum in the last few years. A combinatorial approach for silencing crucial factors essential for tumor progression in cancer-associated immune cells and in cancer cells simultaneously can effectively shift t...
| Main Authors: | , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier,
2016-01-07T16:08:33Z.
|
| Subjects: | |
| Online Access: | Get fulltext |